Australia Últimas notícias

Synertec (ASX:SOP) has secured binding commitments to raise approximately $6 million through an institutional placement of new shares.

Singapore equities are among the world's best performers as strong economic growth, resilient bank earnings and a stronger Singapore dollar attract investors. While some fund managers see further upside, others warn valuations have become increasingly stretched after a multi-year rally.

New South Wales introduced a 75-day fast-tracked planning assessment for data centres meeting six new environmental and community standards.

Steadfast Group (ASX:SDF) extended its exclusivity period to Aug. 21 while negotiating a proposed $7.7 billion cash takeover by a consortium.

Sri Lankan inflation will likely slow back toward the central bank's target over the second half of this year and into next year, central bank Governor Nandalal Weerasinghe tells Bloomberg Television in Sydney. He adds that changes to oil prices remain a risk factor in projections.

OncoSil Medical (ASX:OSL) secured U.S. FDA approval for its OncoSil device to treat distal cholangiocarcinoma, targeting an $80 million market.

American Rare Earths (ASX:ARR) signed a memorandum of understanding with Novex to process rare earth oxides into metals required for permanent magnets.

Kalamazoo Resources (ASX:KZR) announced the appointment of Teresa Pacey as CFO, effective Sept. 28.

Macro Metals (ASX:M4M) executed a non-binding term sheet to sell 100% of its shares in KCM Mining, the registered owner of the Agbaja Iron Ore Project.

Imdex (ASX:IMD) announced record full-year financial results for fiscal 2026, featuring total revenue of $520 million.

L1 Group (ASX:L1G) posted an underlying net profit after tax of $188.8 million for the year ended June 30, marking a 97% increase.

Australian Clinical Labs (ASX:ACL) reported an underlying net profit of $35.5 million for the 2026 financial year.